Dr. Atharhasan Siddiqui Rph.

Dr. AtharHasan Siddiqui, RPh, currently serves as a Value Analyst HE Intern at Adelphi Values, where research focuses on the environmental impacts of switching salmeterol/fluticasone propionate from MDI to DPI in respiratory illness in the United Kingdom. Previous experience includes positions at Labcorp Drug Development, where responsibilities as a Safety Science Coordinator involved training PSS Support Specialists and ensuring compliance with regulatory standards, and as a Safety Science Analyst, processing expedited safety reports for the COVID-19 vaccine. Additionally, Dr. Siddiqui worked as a Clinical Pharmacist at BLDEA's Shri BM Patil Medical College and Hospital, engaging in areas such as ADR detection, medication therapy review, and patient counselling. Academic qualifications include a Master of Science in Health Economics from the University of York and a Doctor of Pharmacy from Rajiv Gandhi University of Health Sciences.